![James Boylan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Boylan
Direktor/Vorstandsmitglied bei
COMPASS THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2026
Profil
James P.
Boylan is Chief Executive Officer & Director at Enavate Sciences since 2022.
He is Independent Director at Immunome, Inc. since 2023, Independent Director at Compass Therapeutics, Inc. since 2022, Director at Graviton Bioscience Corp.
since 2024, Director at Zenas BioPharma (USA) LLC, and Independent Director at Zenas BioPharma, Inc. since 2022.
Former roles include Managing Director at Merrill Lynch & Co., Inc. from 1997 to 2009, Independent Director at CAMP4 Therapeutics Corp.
from 2022 to 2025, President & Head-Investment at SVB Securities Holdings LLC from 2009 to 2021, and President & Head-Investment Banking at Leerink Partners LLC from 2019 to 2021.
Education includes undergraduate studies at Lehigh University and an MBA from Columbia Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
IMMUNOME, INC. -.--% | 10.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
-.--% | 12.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von James Boylan
| Unternehmen | Position | Beginn |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.11.2022 |
| IMMUNOME, INC. | Direktor/Vorstandsmitglied | 02.10.2023 |
Enavate Sciences
 Enavate Sciences Financial ConglomeratesFinance Invests and supports therapeutic & enabling technology companies | Vorstandsvorsitzender | 01.05.2022 |
Zenas Pharma, Inc.
 Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Direktor/Vorstandsmitglied | - |
Graviton Bioscience Corp.
 Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases | Direktor/Vorstandsmitglied | 01.01.2024 |
Ehemalige bekannte Positionen von James Boylan
| Unternehmen | Position | Ende |
|---|---|---|
| CAMP4 THERAPEUTICS CORPORATION | Direktor/Vorstandsmitglied | 09.09.2025 |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Präsident | 01.04.2021 |
SVB Securities Holdings LLC
 SVB Securities Holdings LLC Regional BanksFinance Operates as a bank holding company whose subsidiary provides investment banking services | Präsident | 01.04.2021 |
Merrill Lynch & Co., Inc. /Old/
 Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Corporate Officer/Principal | 01.05.2009 |
Ausbildung von James Boylan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Provides wealth management, securities trading and sales, corporate finance and investment banking services | Finance |
SVB Securities Holdings LLC
SVB Securities Holdings LLC Regional BanksFinance Operates as a bank holding company whose subsidiary provides investment banking services | Finance |
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in the development of regulatory RNA-based therapeutics | Health Technology |
Compass Therapeutics, Inc.
 Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Graviton Bioscience Corp.
Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases | Health Technology |
Enavate Sciences
Enavate Sciences Financial ConglomeratesFinance Invests and supports therapeutic & enabling technology companies | Finance |
Zenas Pharma, Inc.
Zenas Pharma, Inc. BiotechnologyHealth Technology Develops and markets immunology based therapies for patients | Health Technology |
